“…In humans or mouse models with arterial tortuosity syndrome (Cheng et al, 2009; Coucke et al, 2006), Loeys-Dietz syndrome (Gallo et al, 2014; Loeys et al, 2006), Marfan syndrome (Morris et al, 2011), with mutations in genes of the TGFÎČ signaling pathway [ SMAD3 (van de Laar et al, 2011, 2012), TGFB2 (Lindsay et al, 2012), PRKG1 (Guo et al, 2013)] or with mutations in genes directly involved in elastogenesis [ EFEMP2 (Hebson et al, 2014), Fbln5 (Nakamura et al, 2002; Yanagisawa et al, 2002), Ltbp4 (Bultmann-Mellin et al, 2015), Eln (Wagenseil et al, 2009)], aortic or arterial tortuosity is a commonly described feature. Increased aortic tortuosity is associated with a poorer prognosis in aortic diseases (Franken et al, 2015; Hatakeyama et al, 2001; Morris et al, 2011; Shirali et al, 2013), but the detailed mechanisms leading to tortuosity are still unknown (Morris, 2015).…”